Literature DB >> 7213030

Ultrastructural identification of monocyte-derived foam cells in fatty streak lesions.

R G Gerrity, H K Naito.   

Abstract

In a previous publication (1) we demonstrated that atherosclerotic lesion development in the aorta of hypercholesterolemic pigs was preceded by intimal penetration by blood-borne mononuclear cells, and that medial smooth muscle cells were not involved in the development of fatty streak lesions in this model. The current study shows that lesions in the aortic arch do not progress beyond the fatty streak stage up to 30 wk on a hypercholesterolemic diet, and that mononuclear cell involvement continues during this period. Mononuclear cells adherent to the endothelium, or in the intima of lesion areas were identified as monocytes by the presence of peroxidase-positive granules (peroxisomes) in their cytoplasm. As well, "modified" intimal monocytes which contained a few lipid droplets and which were phagocytic, also sometimes contained peroxisomes. The results suggest that monocytes which invade the intima before or during lesion development undergo transformation into macrophage foam cells in fatty streak lesions. The absence of medial cell involvement indicates that monocytes are the major foam cell precursor in these lesions.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7213030

Source DB:  PubMed          Journal:  Artery        ISSN: 0098-6127


  22 in total

Review 1.  The roles of lipid oxidation products and receptor activator of nuclear factor-κB signaling in atherosclerotic calcification.

Authors:  Linda Demer; Yin Tintut
Journal:  Circ Res       Date:  2011-06-10       Impact factor: 17.367

Review 2.  Monocyte and macrophage dynamics during atherogenesis.

Authors:  Klaus Ley; Yury I Miller; Catherine C Hedrick
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-07       Impact factor: 8.311

3.  Characterization of the adhesion of the human monocytic cell line U937 to cultured endothelial cells.

Authors:  P E DiCorleto; C A de la Motte
Journal:  J Clin Invest       Date:  1985-04       Impact factor: 14.808

Review 4.  Clonal Hematopoiesis: Somatic Mutations in Blood Cells and Atherosclerosis.

Authors:  Pradeep Natarajan; Siddhartha Jaiswal; Sekar Kathiresan
Journal:  Circ Genom Precis Med       Date:  2018-07

5.  Immunohistochemical and ultrastructural detection of advanced glycation end products in atherosclerotic lesions of human aorta with a novel specific monoclonal antibody.

Authors:  S Kume; M Takeya; T Mori; N Araki; H Suzuki; S Horiuchi; T Kodama; Y Miyauchi; K Takahashi
Journal:  Am J Pathol       Date:  1995-09       Impact factor: 4.307

Review 6.  The macrophage: the intersection between HIV infection and atherosclerosis.

Authors:  Suzanne M Crowe; Clare L V Westhorpe; Nigora Mukhamedova; Anthony Jaworowski; Dmitri Sviridov; Michael Bukrinsky
Journal:  J Leukoc Biol       Date:  2009-12-01       Impact factor: 4.962

7.  Lipin-1 contributes to modified low-density lipoprotein-elicited macrophage pro-inflammatory responses.

Authors:  Aaron R Navratil; Aimee E Vozenilek; James A Cardelli; Jonette M Green; Michael J Thomas; Mary G Sorci-Thomas; A Wayne Orr; Matthew D Woolard
Journal:  Atherosclerosis       Date:  2015-08-10       Impact factor: 5.162

8.  Conjugated linoleic acid isomers reduce cholesterol accumulation in acetylated LDL-induced mouse RAW264.7 macrophage-derived foam cells.

Authors:  Robert Ringseis; Gaiping Wen; Daniela Saal; Klaus Eder
Journal:  Lipids       Date:  2008-09-04       Impact factor: 1.880

9.  Low density lipoprotein receptor polymorphisms and the risk of coronary heart disease: the Atherosclerosis Risk in Communities Study.

Authors:  N Franceschini; H Muallem; K M Rose; E Boerwinkle; N Maeda
Journal:  J Thromb Haemost       Date:  2009-03       Impact factor: 5.824

10.  Modulation of monocyte-endothelial cell interactions by platelet microparticles.

Authors:  O P Barry; D Praticò; R C Savani; G A FitzGerald
Journal:  J Clin Invest       Date:  1998-07-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.